X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (35) 35
humans (29) 29
oncology (24) 24
female (22) 22
male (22) 22
middle aged (16) 16
tumors (13) 13
aged (12) 12
prognosis (12) 12
adult (11) 11
cancer (11) 11
chemotherapy (11) 11
survival (11) 11
disease-free survival (9) 9
epidemiology (9) 9
medical research (9) 9
patients (9) 9
metastasis (8) 8
analysis (7) 7
clinical trials (7) 7
risk factors (7) 7
treatment outcome (7) 7
antineoplastic combined chemotherapy protocols - therapeutic use (6) 6
chemotherapy, adjuvant (6) 6
cisplatin (6) 6
hematology, oncology and palliative medicine (6) 6
lung neoplasms - drug therapy (6) 6
medical prognosis (6) 6
original reports (6) 6
studies (6) 6
survival analysis (6) 6
vinorelbine plus cisplatin (6) 6
care and treatment (5) 5
children (5) 5
clinical medicine (5) 5
clinical-trials (5) 5
diagnosis (5) 5
expression (5) 5
kaplan-meier estimate (5) 5
medicine, experimental (5) 5
proportional hazards models (5) 5
retrospective studies (5) 5
thromboembolism (5) 5
age (4) 4
aged, 80 and over (4) 4
antineoplastic agents - therapeutic use (4) 4
bayesian analysis (4) 4
biomarkers (4) 4
biomarkers, tumor - genetics (4) 4
cancer therapies (4) 4
carcinoma, non-small-cell lung - drug therapy (4) 4
carcinoma, non-small-cell lung - genetics (4) 4
life sciences (4) 4
lung neoplasms - genetics (4) 4
lung neoplasms - mortality (4) 4
lung neoplasms - pathology (4) 4
medical informatics (4) 4
mutation (4) 4
neoplasm staging (4) 4
pediatrics (4) 4
randomized controlled trials as topic (4) 4
survival rate (4) 4
toxicity (4) 4
trial (4) 4
young adult (4) 4
adjuvant chemotherapy (3) 3
adolescent (3) 3
age factors (3) 3
antimitotic agents (3) 3
antineoplastic agents (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
cancer and oncology (3) 3
cancer och onkologi (3) 3
carcinoma (3) 3
carcinoma, non-small-cell lung - pathology (3) 3
cyclophosphamide (3) 3
disease (3) 3
disease progression (3) 3
efficacy (3) 3
etoposide (3) 3
follow-up (3) 3
follow-up studies (3) 3
france (3) 3
gene expression (3) 3
genes (3) 3
genetic aspects (3) 3
ifosfamide (3) 3
incidence (3) 3
infant (3) 3
intensive induction (3) 3
klinisk medicin (3) 3
medical and health sciences (3) 3
medicin och hälsovetenskap (3) 3
medicine (3) 3
medicine, research & experimental (3) 3
metastases (3) 3
microrna (3) 3
pooled analysis (3) 3
predictive value of tests (3) 3
public, environmental & occupational health (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Bulletin du Cancer, ISSN 0007-4551, 04/2017, Volume 104, Issue 4, p. 388
Dans le numéro 1, volume 104, p. 20–29 du Bulletin du Cancer, une erreur est survenue dans l'orthographe du nom de l'un des auteurs. Il fallait lire Gwénaël Le... 
Journal Article
Computer Methods and Programs in Biomedicine, ISSN 0169-2607, 07/2019, Volume 176, pp. 211 - 223
Journal Article
Statistical Methods in Medical Research, ISSN 0962-2802, 07/2019, p. 96228021986231
In rare diseases, fully powered large trials may not be doable in a reasonable time frame even with international collaborations. In a previous work, we... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2013, Volume 31, Issue 17, pp. 2173 - 2181
Journal Article
Bulletin du Cancer, ISSN 0007-4551, 01/2017, Volume 104, Issue 1, pp. 20 - 29
We present and discuss recent data on the frequency of cancer in France and on cancer survival. In the male population, the incidence of prostate and head and... 
Mortality | France | Epidemiology | Survival | Cancer | Incidence
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2013, Volume 368, Issue 12, pp. 1101 - 1110
Earlier studies suggested that the response to platinum treatment in lung cancer might be predicted according to the presence or absence of the DNA repair... 
SURVIVAL | TRIAL | MEDICINE, GENERAL & INTERNAL | RRM1 | COMPLEMENTATION GROUP 1 | MESSENGER-RNA EXPRESSION | VALIDATION | MONOCLONAL-ANTIBODIES | III BETA-TUBULIN | CHEMOTHERAPY | Epitope Mapping | Lung Neoplasms - drug therapy | Endonucleases - genetics | Lung Neoplasms - mortality | Humans | Immunoglobulin G | Antineoplastic Agents - therapeutic use | Endonucleases - metabolism | DNA-Binding Proteins - metabolism | Protein Isoforms - metabolism | DNA, Neoplasm | Biomarkers, Tumor - metabolism | Chemotherapy, Adjuvant | Lung Neoplasms - genetics | DNA-Binding Proteins - immunology | Carcinoma, Non-Small-Cell Lung - genetics | Kaplan-Meier Estimate | Endonucleases - immunology | Epitopes | DNA-Binding Proteins - genetics | Carcinoma, Non-Small-Cell Lung - mortality | Drug Resistance, Neoplasm - genetics | Cisplatin - therapeutic use | DNA Repair | Carcinoma, Non-Small-Cell Lung - drug therapy | Protein Isoforms - genetics | Usage | Diagnostic immunohistochemistry | Causes of | Genetic aspects | Research | Diagnosis | Gene expression | Lung cancer, Non-small cell | DNA repair | Care and treatment | Lung cancer, Small cell | Health aspects | Cisplatin | Decision making | Lung cancer | DNA damage | Discordance | Clinical trials | Antibodies | Non-small cell lung carcinoma | Nucleotide excision repair | Proteins | Chemotherapy | Lungs | Platinum | Isoforms | Biomarkers | ERCC1 protein | Deoxyribonucleic acid--DNA | Tumors
Journal Article
European Journal of Cancer, ISSN 0959-8049, 12/2016, Volume 69, p. 151
Abstract Background: Patients with germ cell tumours (GCT) receiving cisplatin-based chemotherapy are at high risk of thromboembolic events (TEE). Previously,... 
Anticoagulants | Medical treatment | Prophylaxis | Lactate dehydrogenase | Thrombophlebitis | Risk analysis | Patients | Thrombosis | Cisplatin | L-Lactate dehydrogenase | Molecular chains | Risk factors | Studies | Chemotherapy | Lactic acid | Heparin | Thromboembolism | Surface area | Tumors
Journal Article
European Journal of Cancer, ISSN 0959-8049, 12/2016, Volume 69, p. 151
Background: Patients with germ cell tumours (GCT) receiving cisplatin-based chemotherapy are at high risk of thromboembolic events (TEE). Previously, we... 
Anticoagulants | Dehydrogenases | Prophylaxis | Lactate dehydrogenase | Risk analysis | Thrombosis | Patients | Cisplatin | L-Lactate dehydrogenase | Risk factors | Chemotherapy | Platinum | Lactic acid | Heparin | Thromboembolism | Surface area | Tumors
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2016, Volume 34, Issue 11, pp. 1223 - 1230
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2014, Volume 32, Issue 15_suppl, pp. 4584 - 4584
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2014, Volume 32, Issue 15_suppl, pp. 4573 - 4573
Journal Article
Statistical methods in medical research, 07/2019, p. 962280219862313
In rare diseases, fully powered large trials may not be doable in a reasonable time frame even with international collaborations. In a previous work, we... 
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2012, Volume 7, Issue 2, p. e30313
Diffuse intrinsic pontine glioma (DIPG) is one of the most frequent malignant pediatric brain tumor and its prognosis is universaly fatal. No significant... 
CELLS | MULTIDISCIPLINARY SCIENCES | TUMOR CONSORTIUM | GROWTH-FACTOR | BRAIN-STEM GLIOMAS | RECURRENT MALIGNANT GLIOMAS | STEREOTACTIC BIOPSY | EXPRESSION | IMATINIB MESYLATE | COPY NUMBER ABERRATIONS | CHILDREN | Immunohistochemistry | Receptor, Platelet-Derived Growth Factor alpha - metabolism | Brain Stem Neoplasms - pathology | Humans | Gene Expression Profiling - methods | Signal Transduction - genetics | Transcription Factors - genetics | Epithelial-Mesenchymal Transition - genetics | Brain Stem Neoplasms - metabolism | Transcription Factors - metabolism | Brain Stem Neoplasms - genetics | Receptor, Platelet-Derived Growth Factor alpha - genetics | Mutation | In Vitro Techniques | Snail Family Transcription Factors | Pediatrics | Platelet-derived growth factor | Gliomas | Genes | Brain tumors | Stem cells | Cellular signal transduction | Genetic transcription | Brain | Health sciences | Profiling | Transcription | Mesenchyme | Neuropathology | Brain stem | Genomics | Leukemia | Brain cancer | Oncology | Genomes | Neurosurgery | Kinases | Paraffin | Cancer therapies | Subgroups | Angiogenesis | Regression models | Missense mutation | Blood platelets | Blood-brain barrier | Thalamus | Diagnosis | Growth factors | Bioinformatics | Deoxyribonucleic acid--DNA | Medical research | Breast cancer | Radiation therapy | Gene expression | Patients | Amplification | Brain research | Glioma | Biopsy | Medical prognosis | Transduction | Tumors | Life Sciences | Neurons and Cognition | Deoxyribonucleic acid | DNA
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.